ArticleOncology letters2017

Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.

Xiaodong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.